US 8,507,543 B2Granted

Compounds

AssigneeGlaxo Group Limited

InventorsSimon Teanby Hodgson, Yannick Maurice Lacroix, Panayiotis Alexandrou Procopiou

Life of this patent

Estimating the term…

Abstract

Indazole compounds, processes for their preparation, intermediates usable in these processes, pharmaceutical compositions containing such compounds and their use in therapy.

Claims4

Dependent claims

A method for treating a disease or condition for which a CCR4 receptor antagonist is indicated in a subject in need thereof which comprises administering a therapeutically effective amount of a compound which is

or a salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 13/633,382Filed 2 Oct 2012 · division
Priority: 24 Feb 2010
Published: US 2013/0030031 A131 Jan 2013
Granted: 13 Aug 2013
Term ends: Not estimatedThe source records don’t support an estimate.

Classification28 codes

C07D 409/12
Containing two hetero rings: linked by a chain containing hetero atoms as chain links
A61P 1/00
Drugs for disorders of the alimentary tract or the digestive system
A61P 1/04
Drugs for disorders of the alimentary tract or the digestive system: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of…
A61P 7/02
Drugs for disorders of the blood or the extracellular fluid: antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Family

Application12/711,283Parent of this division · filed 24 Feb 2010
US 2013/0030031 A1Pre-grant publication · published 31 Jan 2013
US 8,304,446 B2Parent of this division
US 2010/0216860 A1Published application
US 8,507,543 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results